These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3784919)

  • 21. Actual status of veralipride use.
    Carranza-Lira S
    Clin Interv Aging; 2010 Sep; 5():271-6. PubMed ID: 20852674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The treatment of hot flashes due to menopause. Comparative study of two drugs (author's transl)].
    Renaud R; Macler J
    Sem Hop; 1981 Feb 18-25; 57(7-8):353-5. PubMed ID: 6261369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of the antidopaminergic drug veralipride on LH and PRL secretion in postmenopausal women.
    Fioretti P; Cagnacci A; Paoletti AM; Gambacciani M; Soldani R; Mauro GA; Spinetti A; Melis GB
    J Endocrinol Invest; 1989 May; 12(5):295-301. PubMed ID: 2549113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical study of veralipride in menopausal sudden flushes (author's transl)].
    Wesel S; L'Hermite M
    Sem Hop; 1980 Oct; 56(37-38):1465-7. PubMed ID: 6254162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of menopausal hot flushes with a nonhormonal medication, veralipride].
    Marzolf G; Eberst B; Aerts A; Lecornu C; Mark J; Gandar R
    Sem Hop; 1982 Nov; 58(41):2382-4. PubMed ID: 6297023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alpha 2-adrenergic mechanism in menopausal hot flushes.
    Freedman RR; Woodward S; Sabharwal SC
    Obstet Gynecol; 1990 Oct; 76(4):573-8. PubMed ID: 2170883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of melatonin in the mediobasal hypothalamus on the secretion of gonadotrophins in sheep: role of dopaminergic pathways.
    Tortonese DJ; Lincoln GA
    J Endocrinol; 1995 Sep; 146(3):543-52. PubMed ID: 7595151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperresponsiveness to the inhibitory action of dopamine agonists on luteinizing hormone secretion in the monosodium-L-glutamate-treated, orchidectomized rat.
    Rose PA; Weick RF
    Neuroendocrinology; 1986; 44(1):95-101. PubMed ID: 3024058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Value of an novel molecule, veralipride, in the treatment of menopausal disorders].
    Grall JY
    Sem Hop; 1982 Nov; 58(43):2535-7. PubMed ID: 6297046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Extrapyramidal adverse effects of veralipride (Agreal), a drug used to treat hot flushes: a propos of 17 cases].
    Masmoudi K; Gras-Champel V; Lemaire-Hurtel AS; Masson H; Munier A; Geslin JM; Andréjak M
    Rev Med Interne; 2005 Jun; 26(6):453-7. PubMed ID: 15936474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bromocriptine associated with a peripheral dopamine blocking agent in treatment of Parkinson's disease.
    Agid Y; Pollak P; Bonnet AM; Signoret JL; Lhermitte F
    Lancet; 1979 Mar; 1(8116):570-2. PubMed ID: 85162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tuberoinfundibular dopaminergic system and anterior pituitary dopamine receptor in Shy-Drager syndrome.
    Konagaya Y; Konagaya M; Takayanagi T
    J Neurol Sci; 1985 Jan; 67(1):93-103. PubMed ID: 3981215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulsatile luteinizing hormone secretion in the ovariectomized, thyroidectomized red deer hind following treatment with dopaminergic and opioidergic agonists and antagonists.
    Anderson GM; Barrell GK
    Biol Reprod; 1998 Oct; 59(4):960-8. PubMed ID: 9746749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Parkinson syndrome induced by veralipride].
    Franchignoni FP; Tesio L
    Minerva Ginecol; 1995 Jun; 47(6):277-9. PubMed ID: 7478098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Veralipride and menopause].
    Laffargue F; Viala JL; Durand G
    Sem Hop; 1983 Sep; 59(29-30):2127-30. PubMed ID: 6312585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathological hyperprolactinemia suppresses hot flashes in menopausal women.
    Scoccia B; Schneider AB; Marut EL; Scommegna A
    J Clin Endocrinol Metab; 1988 Apr; 66(4):868-71. PubMed ID: 3346363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of different dopaminergic antagonists on bromocriptine-induced inhibition of norepinephrine release.
    Mannelli M; Delitala G; De Feo ML; Maggi M; Cuomo S; Piazzini M; Guazzelli R; Serio M
    J Clin Endocrinol Metab; 1984 Jul; 59(1):74-8. PubMed ID: 6725527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Non-hormonal therapy for menopausal disorders: results of a multicentric double-blind trial (author's transl)].
    Linquette M; Rivière J; Vague J
    Sem Hop; 1980 Oct; 56(37-38):1445-8. PubMed ID: 6254159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The physiology and measurement of hot flushes.
    Rebar RW; Spitzer IB
    Am J Obstet Gynecol; 1987 May; 156(5):1284-8. PubMed ID: 3578449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of an antidopaminergic drug on LH, FSH and PRL levels in post-menopausal women.
    Venturini PL; Alibrandi MP; Costantini S; Grondona A; Morano S; Penna L; Valenzano M; Ragni N
    Acta Eur Fertil; 1981 Sep; 12(3):293-4. PubMed ID: 6803504
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.